2024-09-24 - Analysis Report
## Johnson & Johnson (JNJ) Stock Analysis Report

**Company Overview:** Johnson & Johnson is a multinational pharmaceutical, medical device, and consumer packaged goods company.

**Performance Analysis:**

1. **Return Rate Comparison:** JNJ's cumulative return of 37.17% lags behind the S&P 500 (VOO) which has a cumulative return of 132.53%. The current return gap is -95.36%, placing it at the 8.67% percentile of historical return gaps. This suggests JNJ has underperformed the market significantly, but its current position is not the worst it has been in the past. 

2. **Recent Price Action:**  JNJ's recent price action indicates a slight bearish trend. While the closing price is above the 60-day moving average, it is below the 5-day and 20-day moving averages. 

3. **Technical Indicators:**  
    * **RSI (44.48):**  JNJ is in the neutral territory, indicating neither overbought nor oversold conditions. 
    * **PPO (-0.28):** The negative value suggests a potential downward trend, although it is close to zero indicating weak momentum.
    * **Relative Divergence:** The recent (20-day) relative divergence is -3.1, indicating a slight short-term downward trend.
    * **Expected Return:** JNJ has a potential 13.39% expected return over the next 5 years.

4. **Recent Earnings and Outlook:**
    | Date | EPS | Revenue | 
    |---|---|---|
    | 2024-07-25 | 1.95 | 22.45 B$ |
    | 2024-05-01 | 1.35 | 21.38 B$ |
    | 2024-02-16 | 1.68 | 21.39 B$ |
    | 2023-10-27 | 10.32 | 21.35 B$ |
    | 2024-02-16 | 10.32 | 21.35 B$ |

JNJ's recent earnings have been volatile, with EPS showing a decline in the most recent quarter. While the latest revenue is strong, the 2024-07-25 EPS is below analyst estimates. This indicates some potential for the stock price to decline. 

**Overall Analysis:** 

JNJ has underperformed the market significantly in the past. While its recent price action shows a slight bearish trend, its technical indicators and expected return are relatively neutral. The most recent earnings report is mixed, with strong revenue but lower-than-expected EPS. This suggests a potential for the stock price to decline in the short term. 

**Disclaimer:** This is an AI-generated report and should not be considered financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. 
